Protalix BioTherapeutics, Inc. ( $PLX )
Recent earnings result
No new results yet...Join our discord chatroom to get notified as soon as its out.
Next ER estimate scheduled to release on August 13, 2020
Events & Annual meetings
There are no events at this time for this stock.
For list of PLX events, you may visit their Investor Relations website.
Protalix is a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by our proprietary ProCellEx® plant cell-based protein expression system. Our pipeline consists of proprietary, potentially clinically superior versions of recombinant therapeutic proteins that target established pharmaceutical markets.
For list of PLX events, you may visit their Investor Relations website.
Recent results
-
$AGNC - American Capital Agency Corp.
AGNC Investment net spread and dollar roll income beats by $0.11, beats on net interest income
-
$AMKR - Amkor Technology, Inc.
Amkor Technology EPS beats by $0.28, beats on revenue
-
$TESS - TESSCO Technologies Incorporated
TESSCO Technologies EPS beats by $0.05, beats on revenue
-
$NXPI - NXP Semiconductors
NXP Semiconductors EPS beats by $0.18, beats on revenue
-
$MEDP - Medpace Holdings
Medpace EPS beats by $0.28, beats on revenue
-
$FFIV - F5 Networks Inc
F5 Networks EPS beats by $0.14, beats on revenue
-
$RPM - RPM International Inc
RPM EPS beats by $0.14, beats on revenue
-
$HAS - Hasbro Inc
Hasbro EPS misses by $0.21, misses on revenue
-
$SAP - SAP SE
SAP SE EPS beats by €0.03, beats on revenue
-
$CIVB - Civista Bancshares, Inc.
Civista Bancshares EPS beats by $0.17, beats on revenue